Genotypes and Related Factors Reflecting Macrolide Resistance in Pneumococcal Pneumonia Infections in Japan

Journal of Clinical Microbiology

Volumn 45, Issue 5, 2007, Pages 1440-1446

  Isozumi, Rie ^a   Ito, Yutaka ^a   Ishida, Tadashi ^j   Osawa, Makoto ^a   Hirai, Toyohiro ^a   Ito, Isao ^a   Maniwa, Ko ^b   Hayashi, Michio ^c   Kagioka, Hitoshi ^d   Hirabayashi, Masataka ^e   Onari, Koichi ^f   Tomioka, Hiromi ^g   Tomii, Keisuke ^c,h   Gohma, Iwao ^h   Imai, Seiichiro ^a   Takakura, Shunji ⁱ   Iinuma, Yoshitsugu ⁱ   Ichiyama, Satoshi ⁱ   Mishima, Michiaki ^a   Ito, Y ^k   Ishida, T ^k   Hirai, T ^k   Ito, I ^k   Maniwa, K ^k   Hayashi, M ^k   Kagioka, H ^k   Hirabayashi, M ^k   Onari, K ^k   Tomioka, H ^k   Tomii, K ^k   Gohma, I ^k   Mishima, M ^k   more..

^a KYOTO UNIVERSITY   (Japan)

^b KURASHIKI CENTRAL HOSPITAL   (Japan)

^c Ono Municipal Hospital   (Japan)

^d TENRI HOSPITAL   (Japan)

^e KOBE CITY MEDICAL CENTER GENERAL HOSPITAL   (Japan)

^f Kitano Hospital   (Japan)

^g Hyogo Prefectural Tsukaguchi Hospital   (Japan)

^h SAKAI MUNICIPAL HOSPITAL   (Japan)

ⁱ NISHI KOBE MEDICAL CENTER   (Japan)

^j Japan Post   (Japan)

^k NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROMYCIN; MACROLIDE;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; FEMALE; GENOTYPE; HOSPITALIZATION; HUMAN; JAPAN; LOBAR PNEUMONIA; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; COMMUNITY-ACQUIRED INFECTIONS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; GENE EXPRESSION REGULATION, BACTERIAL; GENOTYPE; HUMANS; JAPAN; MACROLIDES; MEMBRANE PROTEINS; METHYLTRANSFERASES; PNEUMONIA, PNEUMOCOCCAL; PREVALENCE;

STREPTOCOCCUS PNEUMONIAE;

EID: 34248585782     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01430-06     Document Type: Article

References (37)

1. Aspa, J., O. Rajas, F. Rodriguez de Castro, J. Blanquer, R. Zalacain, A. Fenoll, R. de Celis, A. Vargas, F. Rodríguez Salvane, P. P. España, J. Rello, A. Torres, et al. 2004. Drug-resistant pneumococcal pneumonia: clinical relevance and related factors. Clin. Infect. Dis. 38:787-798.
2. de Galan, B. E., P. M. B. van Tilburg, M. Sluijter, S. J. M. Mol, R. de Groot, P. W. M. Hermans, and A. R. Jansz. 1999. Hospital-related outbreak of infection with multidrug-resistant Streptococcus pneumoniae in The Netherlands. J. Hosp. Infect. 42:185-192.
3. Dias, R., and M. Caniça. 2004. Emergence of invasive erythromycin-resistant Streptococcus pneumoniae strains in Portugal: contribution and phylogenetic relatedness of serotype 14. J. Antimicrob. Chemother. 54:1035-1039.
4. Farrell, D. J., and D. Felmingham. 2004. Activities of telithromycin against 13,874 Streptococcus pneumoniae isolates collected between 1999 and 2003. Antimicrob. Agents Chemother. 48:1882-1884.
5. Farrell, D. J., S. G. Jenkins, S. D. Brown, M. Patel, B. S. Lavin, and K. P. Klugman. 2005. Emergence and spread of Streptococcus pneumoniae with erm(B) and mef(A) resistance. Emerg. Infect. Dis. 11:851-858.
6. Felmingham, D., R. N. Grüneberg, et al. 2000. The Alexander Project 1996-1997: latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections. J. Antimicrob. Chemother. 45:191-203.
7. Felmingham, D., R. R. Reinert, Y. Hirakata, and A. Rodloff. 2002. Increasing prevalence of antimicrobial resistance among isolates of Streptococcus pneumoniae from the PROTEKT surveillance study, and comparative in vitro activity of the ketolide, telithromycin. J. Antimicrob. Chemother. 50(Suppl. S1):25-37.
8. Gay, K., W. Baughman, Y. Miller, D. Jackson, C. G. Whitney, A. Schuchat. M. M. Farley, F. Tenover, and D. S. Stephens. 2000. The emergence of Streptococcus pneumoniae resistant to macrolide antimicrobial agents: a 6-year population-based assessment. J. Infect. Dis. 182:1417-1424.
9. Hoban. D., F. Baquero, V. Reed, and D. Felmingham. 2005. Demographic analysis of antimicrobial resistance among Streptococcus pneumoniae: worldwide results from PROTEKT 1999-2000. Int. J. Infect. Dis. 9:262-273.
10. Hoban, D. J., G. V. Doern, A. C. Fluit, M. Roussel-Delvallez, and R. N. Jones. 2001. Worldwide prevalence of antimicrobial resistance in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis in the SENTRY antimicrobial surveillance program, 1997-1999. Clin. Infect. Dis. 32(Suppl. 2):S81-S93.
11. Hyde, T. B., K. Gay, D. S. Stephens, D. J. Vugia, M. Pass, S. Johnson, N. L. Barrett, W. Schaffner, P. R. Cieslak, P. S. Maupin, E. R. Zell, J. H. Jorgensen, R. R. Facklam, C. G. Whitney, et al. 2001. Macrolide resistance among invasive Streptococcus pneumoniae isolates. IAMA 286:1857-1862.
12. Inoue, M., N. Y. Lee, S. W. Hong, K. Lee, and D. Felmingham. 2004. PROTEKT 1999-2000: a multicenter study of the antibiotic susceptibility of respiratory tract pathogens in Hong Kong, Japan, and South Korea. Int. J. Antimicrob. Agents 23:44-51.
13. Kasahara, K., E. Kita, K. Maeda, K. Uno, M. Konishi, E. Yoshimoto, K. Murakawa, K. Mikasa, and H. Kimura. 2005. Macrolide resistance of Streptococcus pneumoniae isolated during long-term macrolide therapy: difference between erythromycin and clarithromycin. J. Infect. Chemother. 11: 112-114.
14. Kasahara, K., K. Maeda, K. Mikasa, K. Uno. K. Takahashi, M. Konishi, E. Yoshimoto, K. Murakawa, E. Kita, and H. Kimura. 2005. Clonal dissemination of macrolide-resistant and penicillin-susceptible serotype 3 and penicillin-resistant Taiwan 19F-14 and 23F-15 Streptococcus pneumoniae isolates in Japan: a pilot surveillance study. J. Clin. Microbiol. 43:1640-1645.
15. Ko, K. S., and J. H. Song. 2004. Evolution of erythromycin- resistant Streptococcus pneumoniae from Asian countries that contains erm(B) and mef(A) genes. J. Infect. Dis. 190:739-747.
16. Leclercq, R., and P. Courvalin. 2002. Resistance to macrolide and related antibiotics in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 46:2727-2734.
17. Lefevre, J. C., G. Faucon, A. M. Sicard, and A. M. Gasc. 1993. DNA fingerprinting of Streptococcus pneumoniae strains by pulsed field gel electrophoresis. J. Clin. Microbiol. 31:2724-2728.
18. Lonks, J. R., J. Garau, L. Gomez, M. Xercavins, A. Ochoa de Echagüen, I. F. Gareen, P. T. Reiss, and A. A. Medeiros. 2002. Failure of macrolide antibiotic treatment in patients with bacteremia due to erythromycin-resistant Streptococcus pneumoniae. Clin. Infect. Dis. 35:556-564.
19. Lynch, J. P. III., and F. J. Martinez. 2002. Clinical relevance of macrolide-resistant Streptococcus pneumoniae for community-acquired pneumonia. Clin. Infect. Dis. 34(Suppl. 1):S27-S46.
20. Mandell, L. A., J. G. Bartlett, S. F. Dowell, T. M. File, Jr., D. M. Musher, and C. Whitney. 2003. Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin. Infect. Dis. 37:1405-1433.
21. Moreno, S., M. E. García-Leoni, E. Cercenado, M. D. Diaz, J. C. L. Bernaldo de Quirós, and E. Bouza. 1995. Infections caused by erythromycin-resistant Streptococcus pneumoniae: incidence, risk factors, and response to therapy in a prospective study. Clin. Infect. Dis. 20:1195-1200.
22. National Committee for Clinical Laboratory Standards. 2004. Performance standards for antimicrobial susceptibility testing; fourteenth informational supplement M100-S13. National Committee for Clinical Laboratory Standards, Wayne, PA.
23. Nuermberger, E., and W. R. Bishai. 2004. The clinical significance of macrolide-resistant Streptococcus pneumoniae: it's all relative. Clin. Infect. Dis. 38:99-103.
24. Okamoto, H., K. Tateda, Y. Ishii, T. Matsumoto, T. Kobayashi, and K. Yamaguchi. 2002. High frequency of erythromycin A resistance and distribution of mefE and ermB genes in clinical isolates of Streptococcus pneumoniae in Japan. J. Infect. Chemother. 8:28-32.
25. Olsen, K. M., G. S. San Pedro, L. P. Gann, P. O. Gubbins, D. M. Halinski, and G. D. Campbell, Jr. 1996. Intrapulmonary pharmacokinetics of azithromycin in healthy volunteers given five oral doses. Antimicrob. Agents Chemother. 40:2582-2585.
26. Póvoa, P., L. Coelho, E. Almeida, A. Fernandes, R. Mealha, P. Moreira, and H. Sabino. 2005. C-reactive protein as a marker of ventilator-associated pneumonia resolution: a pilot study. Eur. Respir. J. 25:804-812.
27. Rzeszutek, M., A. Wierzbowski, D. J. Hoban, J. Conly, W. Bishai, and G. G. Zhanel. 2004. A review of clinical failures associated with macrolide-resistant Streptococcus pneumoniae. Int. J. Antimicrob. Agents 24:95-104.
28. Schultz, M. J. 2004. Macrolide activities beyond their antimicrobial effects: macrolides in diffuse panbronchiolitis and cystic fibrosis. J. Antimicrob. Chemother. 54:21-28.
29. Song, J. H., N. Y. Lee, S. Ichiyama, R. Yoshida, Y. Hirakata, W. Fu, A. Chongthaleong, N. Aswapokee, C. H. Chiu, M. K. Lalitha, K. Thomas, J. Perera, T. T. Yee, F. Jamal, U. C. Warsa, B. X. Vinh, M. R. Jacobs, P. C. Appeibaum, C. H. Pai, and the ANSORP Study Group. 1999. Spread of drug resistant Streptococcus pneumoniae in Asian countries: Asian network for surveillance of resistant pathogens (ANSORP) study. Clin. Infect. Dis. 28: 1206-1212.
30. Song, J. H., S. I. Jung, H. K. Ki, M. H. Shin, K. S. Ko, J. S. Son, H. H. Chang, S. W. Kim, H. Lee, Y. S. Kim, W. S. Oh, K. R. Peck, A. Chongthaleong, M. K. Lalitha, J. Perera, T. T. Yee, F. Jamal, A. Kamarulzaman, C. C. Carlos, T. So, et al. 2004. Clinical outcomes of pneumococcal pneumonia caused by antibiotic-resistant strains in Asian countries: a study by the Asian Network for Surveillance of Resistant Pathogens. Clin. Infect. Dis. 38:1570-1578.
31. Sutcliffe, J., T. Grebe, A. Tait-Kamradt, and L. Wondrack. 1996. Detection of erythromycin determinants by PCR. Antimicrob. Agents Chemother. 40: 2562-2566.
32. Suzuki, T., M. Yanai, M. Yamaya, T. Satoh-Nakagawa, K. Sekizawa, S. Ishida, and H. Sasaki. 2001. Erythromycin and common cold in COPD. Chest 120:730-733.
33. Tenover, F. C., R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
34. Ubukata, K., S. Iwata, and K. Sunakawa. 2003. In vitro activities of new ketolide, telithromycin, and eight other macrolide antibiotics against Streptococcus pneumoniae having mefA and ermB genes that mediate macrolide resistance. J. Infect. Chemother. 9:221-226.
35. Vanderkooi, O. G., D. E. Low, K. Green, J. E. Powis, and A. McGeer, et al. 2005. Predicting antimicrobial resistance in invasive pneumococcal infections. Clin. Infect. Dis. 40:1288-1297.
36. Vidaur, L., B. Gualis, A. Rodriguez, R. Ramírez, A. Sandiumenge, G. Sirgo, E. Diaz, and J. Rello. 2005. Clinical resolution in patients with suspicion of ventilator-associated pneumonia: a cohort study comparing patients with or without acute respiratory distress syndrome. Crit. Care Med. 33:1248-1253.
37. Walsh, F., J. Willcock, and S. Amyes. 2003. High-level telithromycin resistance in laboratory-generated mutants of Streptococcus pneumoniae. J. Antimicrob. Chemother. 52:345-353.